We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-13.61%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$2.03B
AUM Growth
-$570M
Cap. Flow
-$189M
Cap. Flow %
-9.31%
Top 10 Hldgs %
6.46%
Holding
2,297
New
383
Increased
673
Reduced
638
Closed
591

Top Buys

Rank Stock Value
1
M icon
Macy's
M
+$17.2M
2
CELG
Celgene Corp
CELG
+$16.3M
3
ABBV icon
AbbVie
ABBV
+$16M
4
AGN
Allergan plc
AGN
+$15.6M
5
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$13.1M

Top Sells

Rank Stock Value
1
MU icon
Micron Technology
MU
+$15.4M
2
ORCL icon
Oracle
ORCL
+$13.9M
3
ADSK icon
Autodesk
ADSK
+$11.6M
4
UNP icon
Union Pacific
UNP
+$11.4M
5
RTN
Raytheon Company
RTN
+$11.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.57%
2 Consumer Discretionary 14.52%
3 Industrials 10.07%
4 Technology 10.02%
5 Financials 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
M icon
1
Macy's
M
$6.15B
$17M 0.84%
331,109
+273,732
+477% +$17.2M
CELG
2
DELISTED
Celgene Corp
CELG
$16.7M 0.82%
154,734
+131,027
+553% +$16.3M
AGN
3
DELISTED
Allergan plc
AGN
$16.4M 0.8%
60,195
+50,779
+539% +$15.6M
ABBV icon
4
AbbVie
ABBV
$458B
$15.9M 0.78%
291,714
+245,495
+531% +$16M
BHC icon
5
Bausch Health
BHC
$1.65B
$12M 0.59%
67,085
+28,186
+72% +$6.57M
MNK
6
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$11.1M 0.55%
173,361
+132,583
+325% +$13.1M
BAX icon
7
Baxter International
BAX
$11.6B
$10.9M 0.54%
+331,369
New +$12.5M
SHW icon
8
Sherwin-Williams
SHW
$78.3B
$10.6M 0.52%
142,482
+117,423
+469% +$10.3M
GOOG icon
9
Alphabet (Google) Class C
GOOG
$3.9T
$10.4M 0.51%
329,720
+249,460
+311% +$7.67M
AMGN icon
10
Amgen
AMGN
$203B
$10.4M 0.51%
75,245
+43,194
+135% +$6.81M
BMRN icon
11
BioMarin Pharmaceuticals
BMRN
$11.5B
$9.72M 0.48%
92,332
+66,366
+256% +$8.86M
PARA
12
DELISTED
Paramount Global Class B
PARA
$9.48M 0.47%
237,553
+100,981
+74% +$4.9M
GILD icon
13
Gilead Sciences
GILD
$161B
$9.16M 0.45%
93,310
+21,447
+30% +$2.38M
HCA icon
14
HCA Healthcare
HCA
$84.8B
$8.87M 0.44%
114,629
+71,608
+166% +$6.34M
META icon
15
Meta Platforms (Facebook)
META
$1.51T
$8.82M 0.43%
+98,119
New +$9M
ALXN
16
DELISTED
Alexion Pharmaceuticals
ALXN
$8.42M 0.41%
53,835
+50,750
+1,645% +$9.26M
REGN icon
17
Regeneron Pharmaceuticals
REGN
$68.8B
$8.29M 0.41%
17,825
+8,666
+95% +$4.65M
VTRS icon
18
Viatris
VTRS
$20.1B
$8.13M 0.4%
201,961
-125,066
-38% -$6.97M
WYNN icon
19
Wynn Resorts
WYNN
$10.1B
$8.08M 0.4%
152,170
+141,200
+1,287% +$12.3M
JAZZ icon
20
Jazz Pharmaceuticals
JAZZ
$15.9B
$7.83M 0.39%
58,975
+50,564
+601% +$8.71M
ILMN icon
21
Illumina
ILMN
$29.4B
$7.8M 0.38%
45,586
+39,441
+642% +$7.97M
BIIB icon
22
Biogen
BIIB
$29.9B
$7.38M 0.36%
25,292
+17,620
+230% +$5.82M
CF icon
23
CF Industries
CF
$19.2B
$7.12M 0.35%
158,648
+147,281
+1,296% +$8.57M
BKNG icon
24
Booking.com
BKNG
$138B
$6.78M 0.33%
137,125
+130,600
+2,002% +$6.49M
QRVO icon
25
Qorvo
QRVO
$7.63B
$6.5M 0.32%
+144,393
New +$8.71M
1
2 3 4 5

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
RC
Roundview Capital Princeton, New Jersey $1.61B AUM 16.92% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
PPW
Parcion Private Wealth Bellevue, Washington $1.61B AUM 31.08% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return

GSA Capital Partners's Q3 2015 Portfolio in Review

As of Q3 2015, GSA Capital Partners held 2,297 positions worth $2.03B, down 22% from $2.6B the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.

GSA Capital Partners withdrew a net $189M in Q3 2015, closing 591 positions and reducing 638 holdings. Its most notable exit was Union Pacific, an estimated $11.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, GSA Capital Partners opened a new position in Baxter International worth $10.9M.

  • GSA Capital Partners's largest Q3 2015 buy was Baxter International: 331,369 shares worth $10.9M.
  • GSA Capital Partners added most to Macy's in Q3 2015, an estimated $17.2M increase.
  • GSA Capital Partners's biggest Q3 2015 reduction was Micron Technology, cutting an estimated $15.4M.
  • GSA Capital Partners fully exited Union Pacific in Q3 2015, selling an estimated $11.4M.
  • GSA Capital Partners's ten largest holdings make up 6.5% of its $2.03B portfolio in Q3 2015.
  • GSA Capital Partners opened 383 new positions and closed 591 in Q3 2015.
  • GSA Capital Partners's portfolio value fell 22% quarter-over-quarter to $2.03B.

Based on GSA Capital Partners's 13F filing for Q3 2015, filed 13 Nov 2015.